In this issue of Urologic Clinics of North America, guest editor Dr. Mark L. Gonzalgo brings his considerable expertise to the topic of Current Management of Superficial Bladder Cancer. Non–muscle-invasive bladder cancer (NMIBC) represents approximately 75% of newly diagnosed bladder cancer cases, making its management a critical focus for urologists worldwide. In this issue, top experts address the evolving landscape of NMIBC care, from innovations in urinary biomarkers and enhanced cystoscopy techniques to advancements in intravesical therapies and personalized molecular treatment.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Epidemiology and Risk Factors for Non–Muscle-Invasive Bladder Cancer: Insights into Prevalence, Risk Stratification, and Implications for Early Diagnosis - p. 343 10. Advances in Diagnosis of Non–Muscle-Invasive Bladder Cancer: A Review - p. 353 11. Transurethral Resection of Bladder Tumors: Evolving Standards of Care—Optimizing Resection, Staging Accuracy, and Recurrence Reduction - p. 365 12. Role of Enhanced Imaging in Superficial Bladder Cancer Management - p. 377 13. Emerging Intravesical Therapies for Non–Muscle-Invasive Bladder Cancer - p. 393 14. Bacillus Calmette-Guérin Therapy: Optimizing Outcomes amid Challenges - p. 413 15. Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer - p. 429 16. Management of High-Risk Non-Muscle-Invasive Bladder Cancer - p. 441 17. Surveillance Protocols: Balancing Patient Burden and Cancer Control - p. 453 18. Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non–Muscle-Invasive Disease - p. 463 19. Patient-Centered Approaches to Non–Muscle-Invasive Bladder Cancer Care - p. 475 20. Economic Considerations in the Management of Superficial Bladder Cancer - p. 487 21. Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care - p. 497 22. Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management - p. 509
In this issue of Urologic Clinics of North America, guest editor Dr. Mark L. Gonzalgo brings his considerable expertise to the topic of Current Management of Superficial Bladder Cancer. Non–muscle-invasive bladder cancer (NMIBC) represents approximately 75% of newly diagnosed bladder cancer cases, making its management a critical focus for urologists worldwide. In this issue, top experts address the evolving landscape of NMIBC care, from innovations in urinary biomarkers and enhanced cystoscopy techniques to advancements in intravesical therapies and personalized molecular treatment.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Epidemiology and Risk Factors for Non–Muscle-Invasive Bladder Cancer: Insights into Prevalence, Risk Stratification, and Implications for Early Diagnosis - p. 343 10. Advances in Diagnosis of Non–Muscle-Invasive Bladder Cancer: A Review - p. 353 11. Transurethral Resection of Bladder Tumors: Evolving Standards of Care—Optimizing Resection, Staging Accuracy, and Recurrence Reduction - p. 365 12. Role of Enhanced Imaging in Superficial Bladder Cancer Management - p. 377 13. Emerging Intravesical Therapies for Non–Muscle-Invasive Bladder Cancer - p. 393 14. Bacillus Calmette-Guérin Therapy: Optimizing Outcomes amid Challenges - p. 413 15. Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer - p. 429 16. Management of High-Risk Non-Muscle-Invasive Bladder Cancer - p. 441 17. Surveillance Protocols: Balancing Patient Burden and Cancer Control - p. 453 18. Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non–Muscle-Invasive Disease - p. 463 19. Patient-Centered Approaches to Non–Muscle-Invasive Bladder Cancer Care - p. 475 20. Economic Considerations in the Management of Superficial Bladder Cancer - p. 487 21. Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care - p. 497 22. Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management - p. 509
